These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29932219)

  • 1. Serum C-reactive protein in the prediction of cardiovascular diseases: Overview of the latest clinical studies and public health practice.
    Avan A; Tavakoly Sany SB; Ghayour-Mobarhan M; Rahimi HR; Tajfard M; Ferns G
    J Cell Physiol; 2018 Nov; 233(11):8508-8525. PubMed ID: 29932219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study.
    Tuomisto K; Jousilahti P; Sundvall J; Pajunen P; Salomaa V
    Thromb Haemost; 2006 Mar; 95(3):511-8. PubMed ID: 16525580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-Reactive protein haplotype predicts serum C-reactive protein levels but not cardiovascular disease risk in a dialysis cohort.
    Zhang L; Kao WH; Berthier-Schaad Y; Plantinga L; Fink N; Smith MW; Coresh J
    Am J Kidney Dis; 2007 Jan; 49(1):118-26. PubMed ID: 17185152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High sensitivity C-reactive protein (hsCRP) & cardiovascular disease: An Indian perspective.
    Kamath DY; Xavier D; Sigamani A; Pais P
    Indian J Med Res; 2015 Sep; 142(3):261-8. PubMed ID: 26458341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?
    Yousuf O; Mohanty BD; Martin SS; Joshi PH; Blaha MJ; Nasir K; Blumenthal RS; Budoff MJ
    J Am Coll Cardiol; 2013 Jul; 62(5):397-408. PubMed ID: 23727085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total cholesterol-to-high-density lipoprotein cholesterol ratio predicts high-sensitivity C-reactive protein levels in Turkish children.
    Agirbasli M; Tanrikulu A; Acar Sevim B; Azizy M; Bekiroglu N
    J Clin Lipidol; 2015; 9(2):195-200. PubMed ID: 25911075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of genetic and environmental factors on hsCRP concentrations and response to therapeutic agents.
    Shen J; Ordovas JM
    Clin Chem; 2009 Feb; 55(2):256-64. PubMed ID: 19074515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of CRP, IL6, and TNFA gene polymorphisms on circulating levels of C-reactive protein in Mexican adolescents.
    Mendoza-Carrera F; Ramírez-López G; Ayala-Martínez NA; García-Zapién AG; Flores-Martínez SE; Sánchez-Corona J
    Arch Med Res; 2010 Aug; 41(6):472-7. PubMed ID: 21044752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein and cardiovascular diseases--is it ready for primetime?
    Lavie CJ; Milani RV; Verma A; O'Keefe JH
    Am J Med Sci; 2009 Dec; 338(6):486-92. PubMed ID: 20010156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper.
    Biasucci LM; ;
    Circulation; 2004 Dec; 110(25):e560-7. PubMed ID: 15611382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between dietary patterns and serum lipids, apo and C-reactive protein in an adult population: evidence from a multi-city cohort in South America.
    Poggio R; Elorriaga N; Gutierrez L; Irazola V; Rubinstein A; Danaei G
    Br J Nutr; 2017 Feb; 117(4):548-555. PubMed ID: 28382894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: ability of inflammatory markers to predict disease in asymptomatic patients: a background paper.
    Wilson PW; ;
    Circulation; 2004 Dec; 110(25):e568-71. PubMed ID: 15611383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of C-reactive protein polymorphisms in inflammation and cardiovascular risk.
    Hage FG; Szalai AJ
    Curr Atheroscler Rep; 2009 Mar; 11(2):124-30. PubMed ID: 19228486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation biomarkers and mortality prediction in patients with type 2 diabetes (ZODIAC-27).
    Landman GW; Kleefstra N; Groenier KH; Bakker SJ; Groeneveld GH; Bilo HJ; van Hateren KJ
    Atherosclerosis; 2016 Jul; 250():46-51. PubMed ID: 27179179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein, inflammation, and cardiovascular disease: clinical update.
    Ridker PM
    Tex Heart Inst J; 2005; 32(3):384-6. PubMed ID: 16392225
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of CCR5-Δ32 deletion on C-reactive protein levels and cardiovascular disease: Results from the Danish Blood Donor Study.
    Dinh KM; Pedersen OB; Petersen MS; Sørensen E; Sørensen CJ; Kaspersen KA; Larsen MH; Møller B; Hjalgrim H; Ullum H; Erikstrup C
    Atherosclerosis; 2015 Sep; 242(1):222-5. PubMed ID: 26222902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function.
    Gruppen EG; Riphagen IJ; Connelly MA; Otvos JD; Bakker SJ; Dullaart RP
    PLoS One; 2015; 10(9):e0139057. PubMed ID: 26398105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease.
    Menon V; Greene T; Wang X; Pereira AA; Marcovina SM; Beck GJ; Kusek JW; Collins AJ; Levey AS; Sarnak MJ
    Kidney Int; 2005 Aug; 68(2):766-72. PubMed ID: 16014054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein and asymmetric dimethylarginine: markers or mediators in cardiovascular disorders?
    Smith CL
    Curr Pharm Des; 2007; 13(16):1619-29. PubMed ID: 17584093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High sensitivity of C-reactive protein in primary prevention].
    Corrado E; Novo S
    G Ital Cardiol (Rome); 2007 Jun; 8(6):327-34. PubMed ID: 17633905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.